Sale of Securities

Tyra Biosciences, Inc. Filed 2026-02-12 Acc 0001628280-26-007756

Documents 1

2026-03-12 144 Sale of Securities
2026-02-17 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-02-13 4 Chief Discovery Officer sold 8,000 shares at an average $32.87 ($262,965)
2026-02-13 SCHEDULE 13G Statement of Beneficial Ownership
2026-02-13 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-02-12 144 Sale of Securities
2026-01-12 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…